Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia

Transplant Proc. 1997 Nov;29(7):3147-9. doi: 10.1016/s0041-1345(97)81731-9.

Authors

S Carlens¹, O Ringdén, M Remberger, J Mattsson, J Aschan, H Hägglund, P Ljungman

Affiliation

¹ Dept of Transplantation Surgery, Huddinge University Hospital, Sweden.

PMID: 9365702
DOI: 10.1016/s0041-1345(97)81731-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Adolescent
Adult
Aged
Analysis of Variance
Bone Marrow Transplantation / mortality
Bone Marrow Transplantation / physiology*
Child
Child, Preschool
Cyclophosphamide / therapeutic use
Disease-Free Survival
Female
Graft vs Host Disease / prevention & control
Histocompatibility Testing
Humans
Immunosuppressive Agents / therapeutic use
Infant
Leukemia / mortality
Leukemia / therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Leukemia, Myeloid / therapy
Living Donors*
Male
Middle Aged
Nuclear Family
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Recurrence
Retrospective Studies
Risk Factors

Substances

Immunosuppressive Agents
Cyclophosphamide